[Dihydroergotamine in the treatment of patients with symptomatic hypotension during regular hemodialysis].

Abstract

The efficacy and safety of dihydroergotamine (DHE, Ditamin) in the treatment of symptomatic hypotension in regularly dialysed patients were tested in comparison to placebo in a single-blind, randomised clinical trial. Ten adult uremic patients (5 men and 5 women) with acute hypotension during hemodialysis, at least once weekly associated with symptoms of… (More)

Topics

Cite this paper

@article{Milutinovi1987DihydroergotamineIT, title={[Dihydroergotamine in the treatment of patients with symptomatic hypotension during regular hemodialysis].}, author={Suzana M Milutinovi{\'c}}, journal={Arzneimittel-Forschung}, year={1987}, volume={37 5}, pages={554-6} }